Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × Genotype × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3 Pancreatic Neoplasms 2 Thyroid Cancer, Papillary 1 Myasthenia Gravis 1 Kidney Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Glioblastoma 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Sunitinib 23 Everolimus 17 aldesleukin 16 Sorafenib 16 Bevacizumab 16 Nivolumab 15 Peripheral Blood Stem Cell Transplantation 13 pembrolizumab 12 fludarabine phosphate 12 Interleukin-2 12 Interferon-alpha 12 Cyclophosphamide 12 Radiotherapy 11 Blood Specimen Collection 11 Radiosurgery 10 Ipilimumab 10 Gemcitabine 10 Filgrastim 9 Axitinib 9 Gene Expression Profiling 7 temsirolimus 6 Surveys and Questionnaires 6 Surgical Procedures, Operative 6 Cryosurgery 6 pazopanib 5 durvalumab 5 cabozantinib 5 Mycophenolic Acid 5 Immunohistochemistry 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02404584 2025-12-04

GenCInibs-Suni

Centre Hospitalier Universitaire de Nīmes

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡